Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P16112: Variant p.Asp2381Asn

Aggrecan core protein
Gene: ACAN
Feedback?
Variant information Variant position: help 2381 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Aspartate (D) to Asparagine (N) at position 2381 (D2381N, p.Asp2381Asn). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and acidic (D) to medium size and polar (N) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In SEMDAG; creates a functional N-glycosylation site; does not adversely affect protein trafficking and secretion. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 2381 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 2530 The length of the canonical sequence.
Location on the sequence: help PEEQEFVNNNAQDYQWIGLN D RTIEGDFRWSDGHPMQFENW The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         PEEQEFVNNNAQDYQWIGLNDRTIEGDFRWSDGHPMQFENW

                              PEEQEFVNNNAQDYQWIGLNDRTIEGDFRWSDGHSLQFENW

Mouse                         PEEQEFVNKNAQDYQWIGLNDRTIEGDFRWSDGHSLQFEKW

Rat                           PEEQEFVNKNAQDYQWIGLNDRTIEGDFRWSDGHSLQFEKW

Bovine                        PEEQEFVNNNAQDYQWIGLNDKTIEGDFRWSDGHSLQFENW

Chicken                       PEEQEFVNSHAQDYQWIGLSDRAVENDFRWSDGHSLQFENW
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 17 – 2530 Aggrecan core protein
Chain 393 – 2530 Aggrecan core protein 2
Domain 2327 – 2441 C-type lectin
Region 2278 – 2530 G3
Binding site 2381 – 2381
Binding site 2385 – 2385
Binding site 2385 – 2385
Disulfide bond 2348 – 2440



Literature citations
A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan.
Tompson S.W.; Merriman B.; Funari V.A.; Fresquet M.; Lachman R.S.; Rimoin D.L.; Nelson S.F.; Briggs M.D.; Cohn D.H.; Krakow D.;
Am. J. Hum. Genet. 84:72-79(2009)
Cited for: VARIANT SEMDAG ASN-2381; CHARACTERIZATION OF VARIANT SEMDAG ASN-2381;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.